Breast cancer interventional device company SenoRx said that it has received a transitional device pass-through reimbursement code for its tissue localization excision medical device products from the Centers for Medicare and Medicaid Services (CMS).
The new code, C1819, will be effective January 1, 2004, and will apply to the Aliso Viejo, CA-based company’s SenoRx Anchor Guide device.
By AuntMinnie.com staff writers
November 25, 2003
Related Reading
More breast markers available as usage becomes standard practice, August 26, 2003
US-guided biopsy marker takes clear aim at breast lesions, May 5, 2003
U.K. researchers explore reasons for biopsy clip movement, March 8, 2003
New adjunctive breast techniques improve positive biopsy rates, February 25, 2003
Post-biopsy gel marker stays put on mammographic follow-up, December 5, 2002
Copyright © 2003 AuntMinnie.com
